These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17112623)

  • 41. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
    Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
    Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biological markers of hepatocellular carcinoma].
    Deugnier Y; Auffret P; Lehry D; Brissot P; Bourel M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):648-57. PubMed ID: 2826282
    [No Abstract]   [Full Text] [Related]  

  • 44. [A comparison of the individual alpha-fetoproteins of human fetuses and patients with primary liver cancer].
    Gusev AI; Iazova AK; Poliakova EV
    Biull Eksp Biol Med; 1971 Mar; 71(3):69-72. PubMed ID: 4327500
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-1 fetoglobulin in the diagnosis of human hepatoma.
    Alpert ME; Uriel J; de Nechaud B
    N Engl J Med; 1968 May; 278(18):984-6. PubMed ID: 4171303
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N; Satomura Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract]   [Full Text] [Related]  

  • 48. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Early diagnosis of hepatocellular carcinoma].
    Lorenzo Romo I; Tovar Zapata I; Casas Pina T; Martínez Hernández P
    Gastroenterol Hepatol; 1996; 19(7):390. PubMed ID: 8963911
    [No Abstract]   [Full Text] [Related]  

  • 50. [Alpha 1 fetoglobulin and hepatoma].
    Mukojima T; Hattori N
    Gan No Rinsho; 1971 Jun; 17(6):419-23. PubMed ID: 4326804
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients.
    Tanabe K; Deguchi A; Higashi M; Usuki H; Suzuki Y; Uchimura Y; Kuriyama S; Ikenaka K
    Biochem Biophys Res Commun; 2008 Sep; 374(2):219-25. PubMed ID: 18619944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
    Yolcu OF; Köklü S; Yüksel O; Coban S; Ayaz S; Akif Oztürk M; Benekli M
    Hepatogastroenterology; 2007; 54(77):1526-8. PubMed ID: 17708290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical study of hepatocellular carcinoma-specific aldehyde dehydrogenase.
    Shibuya A; Takeuchi A; Shibata H; Saigenji K; Yoshida A
    Alcohol Alcohol Suppl; 1994; 29(1):119-23. PubMed ID: 9063810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum ferritin as a tumor marker in patients with solid neoplasms.
    Pavesi F; Lotzniker M; Marbello L; Garbagnoli P; Acquistapace L; Moratti R
    Haematologica; 1987; 72(5):415-9. PubMed ID: 2826315
    [No Abstract]   [Full Text] [Related]  

  • 56. [The problem of immunochemical diagnosis of primary cancer of the liver].
    Assekrutova IV; Abelev GI; Kraevskiĭ NA; Perova SD; Perevodchikova NI
    Vestn Akad Med Nauk SSSR; 1967; 22(5):75-81. PubMed ID: 4174294
    [No Abstract]   [Full Text] [Related]  

  • 57. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Polycythemia as a paraneoplastic syndrome in hepatocellular carcinoma].
    Häufle M; Walker S; Bode JC
    Med Klin (Munich); 1994 Nov; 89(11):626-8. PubMed ID: 7815994
    [No Abstract]   [Full Text] [Related]  

  • 59. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical evaluation of serum tissue polypeptide antigen (TPA) in hepatocellular carcinoma].
    Tanaka N; Yamada S; Tsuchiya M; Etoh K
    Fukuoka Igaku Zasshi; 1984 Sep; 75(9):568-73. PubMed ID: 6097524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.